Response to comment on Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial

Eye

Volumn 25, Issue 6, 2011, Pages 820-

  Subramanian, M L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

HUMAN; LETTER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA AGE RELATED DEGENERATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

EID: 79958744063     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.16     Document Type: Letter

References (1)

1. Subramanian ML, Abedi G, Ness S, Ahmed E, Fenberg M, Daly MK et al. Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial. Eye 2010;24:1708-1715.